Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness
Year of publication: |
2006
|
---|---|
Authors: | Karnon, Jonathan |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 24.2006, 3, p. 215-232
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Advanced-breast-cancer | Anastrozole | Aromatase-inhibitors | Cost-effectiveness | Early-breast-cancer | Exemestane | Letrozole | Tamoxifen |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Annemans, Lieven, (2008)
-
Karnon, Jon, (2003)
-
Management of Advanced Breast Cancer: Defining the Role of Anastrozole
Keating, Gillian M., (2001)
- More ...
-
A proposed model for economic evaluations of major depressive disorder
Haji Ali Afzali, Hossein, (2012)
-
Discrete event simulation for health technology assessment
Caro, J. Jaime, (2016)
-
Karnon, Jonathan, (2013)
- More ...